Major hepatectomy for intrahepatic cholangiocarcinoma or colorectal liver metastases. Are we talking about the same story?
Fiche publication
Date publication
décembre 2019
Journal
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PESSAUX Patrick, Pr HEYD Bruno
Tous les auteurs :
Doussot A, Fuks D, Regimbeau JM, Farges O, Sa-Cunha A, Pruvot FR, Adam R, Navarro F, Azoulay D, Heyd B, Pessaux P,
Lien Pubmed
Résumé
Major hepatectomy (MH) is often needed in the curative management of intrahepatic cholangiocarcinoma (IHCC) and colorectal liver metastases (CRLM). While similar outcomes could be expected after MH for IHCC and CRLM, outcomes seem worse after MH for IHCC. A better understanding of such differences might help improving perioperative outcomes but comprehensive analysis are lacking.
Mots clés
Colorectal liver metastases, Intrahepatic cholangiocarcinoma, Liver-related complications, Major hepatectomy, Postoperative outcomes
Référence
Eur J Surg Oncol. 2019 Dec;45(12):2353-2359